References
- Bergeron MG, Lavoie GY, Boucher FDW. Comparative bactericidal activity of cefixime, carumonam, enoxacin and roxithromycin with those of other antibiotics against resistant Haemophilus influenzae including β-lactam tolerant strains. J Antimicrob Chemother 1987; 20: 663–669.
- Hadorn K, Kayser FH. Antibakterielle Aktivität von Cefixim im Vergleich mit oralen Cephalosporinen und weiteren Antibiotika. In Paul-Ehrlich-Gesellschaft/W. Stille, D. Adam (Eds.) Neue Oralcephalosporine. FAC 6–8. Fortschr. Antimikr. Antineoplast. Chemother. Ruturamed Verlag, München, 1987: 1213–1222.
- Neu HC, Chin NX, Labthavikul P. Comparative in vitro activity and betalactamase stability of FR 17027, a new orally active cephalosporin. Antimicrob Agents Chemother. 1984; 24 (3): 174–180.
- Simon C. Zur in-vitro Aktivität von Cefixim im Vergleich zu anderen Oral cephalosporinen. In Paul-Ehrlich-Gesellchaft/W. Stille, D. Adam (Eds.) Neue Oralcephalosporine. FAC 6–8. Fortschr. Antimikr. Antineoplast. Chemother. Futuramed Verlag, München. 1987: 1193–1196.
- Kiani R, Johnson D, Nelson B. Clinical results of cefixime 200 mg b.i.d. in the treatment of patients with acute respiratory tract infections. In P. Kuemmerle (Eds.) Advances in Experimental and Clinical Chemotherapy. Workshop New Oral Cephalosporin Antibiotic – Cefixime. Vol. 1/88. Ecomed Verlagsgesellschaft mbH, Landsberg, FRG, 1988.
- Oizumi K, S aito A, Hayashi I. Therapeutic efficacy of FK 027 in the treatment of respiratory tract infections. In R. C. Noellering, jr., K. Shimada (Eds.), A Review of New Oral Cephems. Proceedings of a workshop held at the 14th International Congress of Chemotherapy, Kyoto. University of Tokyo Press. 1985: 41–46.